Nymox Pharmaceutical Corp

NASDAQ:NYMX   3:59:55 PM EDT
1.73
-0.02 (-1.14%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Nymox Pharmaceutical Corp Stock, NASDAQ:NYMX

Bay & Deveaux Streets, 2nd Floor, Nassau, New Providence H4M 2V2
Phone: +1.800.936.9669
Number of Employees: 3

Description

Nymox Pharmaceutical Corp. operates as a biopharmaceutical company, which engages in the research and development on products for the aging population. Its products include NicAlert and TobacAlert, and the NX-1207 for the treatment of low-grade localized prostate cancer. It operates through the following geographical segments: Canada, United States, and Europe. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.